Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M van Buskirk

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
Transfusion|July 6, 2021
The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance studyJoseph H Cho, Srijana Rajbhandary, Nancy L van Buren, et al.
Transfusion|December 23, 2022
Demographics of first-time donors returning for donation during the pandemic: COVID-19 convalescent plasma versus standard blood product donorsNancy L Van Buren, Srijana Rajbhandary, Vanessa Reynolds, et al.
Mayo Clinic Proceedings|November 6, 2020
Recruitment Strategy for Potential COVID-19 Convalescent Plasma DonorsKylie J Andersen, Stephen A Klassen, Kathryn F Larson, et al.
Frontiers in Medicine|November 3, 2025
COVID-19 convalescent plasma for B-cell depleted patients: a systematic review and individual patient data meta-analysisSolomiia Zaremba, Daniele Focosi, Wyatt W Pruter, et al.
The Journal of Clinical Investigation|June 12, 2020
Early safety indicators of COVID-19 convalescent plasma in 5000 patientsMichael J Joyner, R Scott Wright, DeLisa Fairweather, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month ExperienceMichael J Joyner, Jonathon W Senefeld, Stephen A Klassen, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasmaJonathon W Senefeld, Patrick W Johnson, Katie L Kunze, et al.
The New England Journal of Medicine|February 1, 2021
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19Michael J Joyner, Rickey E Carter, Jonathon W Senefeld, et al.
Mayo Clinic Proceedings|August 31, 2020
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized PatientsMichael J Joyner, Katelyn A Bruno, Stephen A Klassen, et al.
Nature Communications|August 12, 2021
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donorsKatie L Kunze, Patrick W Johnson, Noud van Helmond, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Transfusion|July 6, 2021
The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance studyJoseph H Cho, Srijana Rajbhandary, Nancy L van Buren, et al.
Transfusion|December 23, 2022
Demographics of first-time donors returning for donation during the pandemic: COVID-19 convalescent plasma versus standard blood product donorsNancy L Van Buren, Srijana Rajbhandary, Vanessa Reynolds, et al.
Mayo Clinic Proceedings|November 6, 2020
Recruitment Strategy for Potential COVID-19 Convalescent Plasma DonorsKylie J Andersen, Stephen A Klassen, Kathryn F Larson, et al.
Frontiers in Medicine|November 3, 2025
COVID-19 convalescent plasma for B-cell depleted patients: a systematic review and individual patient data meta-analysisSolomiia Zaremba, Daniele Focosi, Wyatt W Pruter, et al.
The Journal of Clinical Investigation|June 12, 2020
Early safety indicators of COVID-19 convalescent plasma in 5000 patientsMichael J Joyner, R Scott Wright, DeLisa Fairweather, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month ExperienceMichael J Joyner, Jonathon W Senefeld, Stephen A Klassen, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasmaJonathon W Senefeld, Patrick W Johnson, Katie L Kunze, et al.
The New England Journal of Medicine|February 1, 2021
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19Michael J Joyner, Rickey E Carter, Jonathon W Senefeld, et al.
Mayo Clinic Proceedings|August 31, 2020
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized PatientsMichael J Joyner, Katelyn A Bruno, Stephen A Klassen, et al.
Nature Communications|August 12, 2021
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donorsKatie L Kunze, Patrick W Johnson, Noud van Helmond, et al.
Pageof 17